Emil Pot
Oprichter bij Intrexon ActoBiotics NV
Oorsprong van het eerstegraads netwerk van Emil Pot
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium.
18
| Subsidiary | Biotechnology | 18 |
Allero Therapeutics BV
 Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Allero Therapeutics BV is a biopharmaceutical company, which engages in the development of immunotherapies. It focuses on the research and development pipeline with a focus on a celiac disease product and a food allergy product. The company was founded by Poul Sorensen, Emil Pot, Federico Grego, and Kees Leenhouts and is headquartered in Rotterdam, the Netherlands.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Emil Pot via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pacira CryoTech, Inc.
 Pacira CryoTech, Inc. Medical/Nursing ServicesHealth Services Pacira Cryotech, Inc. develops novel technologies for treatment of peripheral nerves. Its iovera treatment harnesses the power of cold with the Focused Cold Therapy delivery system and delivers immediate results for both therapeutic and aesthetic applications. The firm’s iovera treatment does not use toxins, chemicals, or pharmaceuticals to achieve results and leaves nothing behind in the body. The company was founded by Lisa Elkins in 2005 and is headquartered in Fremont, CA. | Medical/Nursing Services | Director/Board Member | |
| SQZ BIOTECHNOLOGIES COMPANY | Biotechnology | Director/Board Member | |
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Investment Managers | Corporate Officer/Principal | |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Chairman | |
CropDesign NV
 CropDesign NV Miscellaneous Commercial ServicesCommercial Services CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium. | Miscellaneous Commercial Services | Director/Board Member President Director of Finance/CFO Director of Finance/CFO | |
| ABLYNX | Biotechnology | Director/Board Member Chief Executive Officer | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree | |
| Ghent University | College/University | Graduate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree | |
| Université Libre de Bruxelles | College/University | Undergraduate Degree Doctorate Degree | |
| University College Cork | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Vlerick Leuven Gent Management School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| OXURION NV | Pharmaceuticals: Major | Director of Finance/CFO Chairman | |
Vlaams Instituut voor Biotechnologie - Flanders Institute
 Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | College/University | Chief Executive Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Janssen Pharmaceutica NV
 Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Pharmaceuticals: Major | Chief Executive Officer | |
| Université Catholique de Louvain | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| The Janssen Research Foundation | President | ||
Complix NV
 Complix NV Pharmaceuticals: MajorHealth Technology Complix NVengages in the development of biopharmaceutical company developing Alphabodies, a pipeline of transformative protein therapeutics. The Company is currently focusing its internal research and development activities on oncology and autoimmune diseases. Its therapeutic Alphabodies focuses on the treatment of autoimmune diseases, such as rheumatoid arthritis, psoriasis and multiple sclerosis, and infectious diseases, and viral diseases such as influenza, HIV, and RSV. The company was founded by Mark Vaeck and Ignace Lasters in 2008 and is headquartered in Diepenbeek, Belgium. | Pharmaceuticals: Major | Director/Board Member Founder | |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Director/Board Member Chairman Chairman | |
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Medical Specialties | Director/Board Member | |
Bayer Bioscience NV
 Bayer Bioscience NV Chemicals: AgriculturalProcess Industries Part of Bayer AG, Bayer Bioscience NV is a Belgian company that manufactures and markets herbicides and agricultural chemical products. The company is based in Ghent, Belgium. The company was founded by Gerard van Acker. | Chemicals: Agricultural | Corporate Officer/Principal Corporate Officer/Principal | |
Novo Nordisk Scandinavia AB
 Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Het Vlaams Parlement | Corporate Officer/Principal | ||
| Viziphar Biosciences BV | Chief Executive Officer | ||
| Vivactis NV | Miscellaneous | Director/Board Member | |
| University of Antwerp | College/University | Graduate Degree Graduate Degree | |
Q-Biologicals NV
 Q-Biologicals NV BiotechnologyHealth Technology Q-Biologicals NV operates as a bio pharma contract development and manufacturing organization. It provides process development and bio manufacturing services to customers in the biopharmaceutical industry. The company was founded in 2011 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
| MENDUS AB | Biotechnology | Director/Board Member | |
| BIOTALYS NV | Chemicals: Agricultural | Director/Board Member Director/Board Member | |
| IDOGEN AB (PUBL) | Biotechnology | Sales & Marketing | |
Biogazelle NV
 Biogazelle NV BiotechnologyHealth Technology Biogazelle NV is a research and development stage biotechnology firm. It specializes in ribonucleic acid for next generation diagnostics in the field of oncology and other diseases. The company was founded by Jan Hellemans and Jo Vandesompele in 2007 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member | |
| BIOCARTIS GROUP NV | Medical Specialties | Director/Board Member | |
DoseVue NV
 DoseVue NV Medical SpecialtiesHealth Technology DoseVue NV is developing innovative technologies for convenient and accurate in-vivo dosimetry. It offers DoseWire Series 100 & DoseWire Series 200. The company was founded by Emiliano D Agostino in March 2013 and is headquartered in Turnhout, Belgium. | Medical Specialties | Chairman | |
| PLIANT THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
MonTa Biosciences ApS
 MonTa Biosciences ApS BiotechnologyHealth Technology MonTa Biosciences ApS engages in research and development in biotechnology for cancer immunotherapy. Its technology offers a solution to deliver immune stimulating compounds directly to immune cells in the blood. The company was founded by Thomas Lars Andresen, Jonas Henriksen, and Simon Skjøde Jensen in August 2014 and is headquartered in Brønshøj, Denmark. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Calypso Biotech BV
 Calypso Biotech BV BiotechnologyHealth Technology Calypso Biotech BV operates as immunotherapy biotech company. It develops monoclonal antibodies for the treatment of immune pathologies with large unmet medical needs. The company was founded by Alain Vicari and Yolande Chvatchko in 2013 and is headquartered in Amsterdam, the Netherlands. | Biotechnology | Chairman | |
| ECTIN RESEARCH AB | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Glazer Consulting Holding ApS | Chief Tech/Sci/R&D Officer | ||
DeuterOncology SA
 DeuterOncology SA BiotechnologyHealth Technology DeuterOncology SA is a Belgian preclinical-stage biotechnology company that specializes in developing targeted cancer therapies. DeuterOncology is based in Liege, BE. The company's focus is on creating a first-in-class dual MET and RAS pathway inhibitor. The company was founded in 2020 by Timothy Perera, who has been the CEO since 2020. | Biotechnology | Chairman | |
Strebo Services Srl
 Strebo Services Srl Medical/Nursing ServicesHealth Services Strebo Services Srl operates rest and care homes. The private company is based in La Louvière, Belgium. The Belgian company was founded in 2008. The CEO is Stéphane Mercier. | Medical/Nursing Services | Director/Board Member |
Statistieken
Internationaal
| België | 30 |
| Verenigde Staten | 9 |
| Zweden | 6 |
| Denemarken | 5 |
| Nederland | 3 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 10 |
| Health Services | 4 |
| Commercial Services | 4 |
| Process Industries | 3 |
Operationeel
| Director/Board Member | 122 |
| Corporate Officer/Principal | 40 |
| Chief Executive Officer | 18 |
| Independent Dir/Board Member | 16 |
| Chairman | 15 |
Sterkste connecties
| Insiders | |
|---|---|
| Chris Buyse | 39 |
| Patrick van Beneden | 28 |
| Mounia Chaoui-Roulleau | 27 |
| Staf van Reet | 22 |
| Johan Cardoen | 19 |
| Jos Sluys | 17 |
| Bernard Coulie | 13 |
| Steven Glazer | 12 |
| Flemming Steen Jensen | 10 |
| Mark Vaeck | 10 |
| Decebal Bora | 7 |
| Patrick Dhaese | 5 |
| Lothar Steidler | 4 |
| Magda van Hijfte | 4 |
| Pieter Rottiers | 3 |
